This document discusses Dhanyamla Bahiparimarjana, or external cleansing treatments using fermented rice. It defines Bahiparimarjana as external treatment procedures involving touch, like oil massages, sweating treatments, and poultices. While Bahiparimarjana helps relieve diseases, it does not eliminate toxins from the body like internal cleansing methods. Dhanyamla is a fermented mixture used in Bahiparimarjana to treat wind and vata-kapha disorders. The document outlines the traditional method for preparing Dhanyamla and its properties and indications.
A Guest lecture organised by Agnivesha Ayurveda Academy Bangalore; have invited to Dr. Lohith B. A. M.D., PhD. Head & Professor, Department of Panchakarma , SDM college of Ayurveda & Hospital, Hassan
To deliver the lecture on "Panchakarma and its advancement" on 27/04/2017
This is the second part of presentation regarding definitions in Rasa shastra. An attempt is made to clarify the definitions in more clear way also useful images are added to further improvise the presentation.
A Guest lecture organised by Agnivesha Ayurveda Academy Bangalore; have invited to Dr. Lohith B. A. M.D., PhD. Head & Professor, Department of Panchakarma , SDM college of Ayurveda & Hospital, Hassan
To deliver the lecture on "Panchakarma and its advancement" on 27/04/2017
This is the second part of presentation regarding definitions in Rasa shastra. An attempt is made to clarify the definitions in more clear way also useful images are added to further improvise the presentation.
Role of Ayurvedic drugs in KASA (COUGH)
Dr. Rajtilak Tiwari M.D. ( Kayachikitsa)
{Assistant Professor in Kayachikitsa dept. in Shivshakti lal sharma Ayurvedic College Ratlam (M.P.)}
Gandusha it is an one of the theory that in which rinse the doshas that situated in the oral cavity and Mukha lepa is also an procedure it protect the face that free from any reactions.
Kayachikitsa IMP Schlok – Part 1 - PPT
By Prof. Dr. R. R. Deshpande
• This PPT has following features –
• Imp Contents – Definition of Chikitsa, Definition of Sharir, Chatushpad, Chikitsa dhistit Purush, Pathya –Apathya, Yukti Vyapashraya Chikitsa, Santarponattha Vyadhi, Vyadhi Samprapti, Causes of Vata,Pitta & Kapha Prakop, Shat Kriya Kal, Clinical Features of Vata,Pitta & Kapha Prakop, Vyadhi kshamatva,Dosha Pak & Dhatu Pak,Aam etc
• Visit – www.ayurvedicfriend.com
Phone – 922 68 10 630
Sandhigata Vata is the type of pathogenesis involved in various disease conditions affecting the joints, e.g. osteoarthritis, rheumatoid arthritis, etc. and causing pain in affected joints.
Role of Ayurvedic drugs in KASA (COUGH)
Dr. Rajtilak Tiwari M.D. ( Kayachikitsa)
{Assistant Professor in Kayachikitsa dept. in Shivshakti lal sharma Ayurvedic College Ratlam (M.P.)}
Gandusha it is an one of the theory that in which rinse the doshas that situated in the oral cavity and Mukha lepa is also an procedure it protect the face that free from any reactions.
Kayachikitsa IMP Schlok – Part 1 - PPT
By Prof. Dr. R. R. Deshpande
• This PPT has following features –
• Imp Contents – Definition of Chikitsa, Definition of Sharir, Chatushpad, Chikitsa dhistit Purush, Pathya –Apathya, Yukti Vyapashraya Chikitsa, Santarponattha Vyadhi, Vyadhi Samprapti, Causes of Vata,Pitta & Kapha Prakop, Shat Kriya Kal, Clinical Features of Vata,Pitta & Kapha Prakop, Vyadhi kshamatva,Dosha Pak & Dhatu Pak,Aam etc
• Visit – www.ayurvedicfriend.com
Phone – 922 68 10 630
Sandhigata Vata is the type of pathogenesis involved in various disease conditions affecting the joints, e.g. osteoarthritis, rheumatoid arthritis, etc. and causing pain in affected joints.
Much is being discussed about evidence based Ayurveda or Ayurveda doesn't has quality standards, neither has protocols or SOPs for drugs, treatment, hospitals and its procedural specialties like Panchkarma and Ksharsutra.
Now Department of ayush engaged quality council of India and NABH for voluntary certification of quality for- ASU products on the basis of third party evaluation. NABH- National accreditation board for health services laid down certain accreditation standards for Ayurveda Hospitals.
GEOLOGICAL FIELD SURVEY TO KUMARAMALAI REGIONS OF SANDUR – HADDINAPADE IRON ORE MINES OF BELLARY DISTRICT-KARNATAKA, BY-
DR.M.GOPI KRISHNA
ASST-PROFFESOR
DEPT. OF RASA SHASTRA
S.J.G.AYURVEDIC MEDICAL COLLEGE AND P.G RESEARCH CENTRE, KOPPAL, KARNATAKA
Guest Lecture by Ayurmitra Prof. KSR Prasad on Crisis Management in Ayurveda Medicine, A CME of Kayachikitsa
@ Mahatma Gandhi Ayurved College Hospital & Research Center, Salod (H), Wardha, Maharastra
On – 02-03-2013
Ayurveda Research Vision 2020 by Ayurmitra Dr. K. Shiva Rama Prasad, at http://www.technoayurveda.com/
Guest lecture at DrBRKR GAC, Hyderabad, Andhra Pradesh, on 26-03-14
TRANSDERMAL THERAPEUTIC DRUG DELIVERY SYSTEMS N Anusha
Transdermal drug delivery systems (TDDS) can be defined as self-contained discrete dosage forms which, when applied to the intact skin, delivers the drug(s) through the skin at a controlled rate to the systemic circulation.
For transdermal drug delivery, it is considered ideal if the drug penetrates through the skin to the underlying blood supply without drug buildup in the dermal layers.
They provide extended therapy with a single application, thereby improving patient compliance over other dosage forms requiring more frequent dose administration.
1.1 Pharmacology- An Introduction
The word pharmacology is derived from two Greek words, pharmacon meaning a drug, and logos meaning an opinion or reason. It can be defined as
“The science which deals with the history, source, physical properties, chemical properties, compounding, biochemical effects, physiological effects, mechanism of action, absorption, distribution, biotransformation, excretion, therapeutic and other uses of drugs, is called pharmacology.”
“The study of a substance that interacts with the living system through chemical processes especially by binding to regulatory molecules and activates or inhibits normal body processes”
“The science of substances used to prevent, diagnose and treat disease.”
Drug:
The word drug comes from Drogue meaning a dry herb. A drug can be defined as:
“A substance, material or product used for the purpose of diagnosis, prevention and relief of symptoms or cure of disease.”
WHO defines drug as:
“A substance, material or product used or intended to be used to modify or explore the physiological processes or pathological states for the benefit of the recipient.”
General Features of a Drug:
• Variability in molecular size
• Variability in shape
• Variability in chemical nature
• Variability in lipid/water partition coefficient
• Variability in degree of ionization
• Physical Properties
• Variability in molecular size
Smaller sized molecules are easily absorbed than larger molecules. Normally the molecular weight is between 100-1000 but may be higher or lower. Streptokinase is an example of large molecular weight drug while lithium or nitric oxides are of small molecular weight.
• Variability in shape
Training Program for Panchakarma Assistant
(20-24/05-2024)
Department of Panchkarma, Gurukul Campus
Uttarakhand Ayurved University, Haridwar, Uttarakhand
Training Program for Panchakarma Assistant
(20-24/05-2024)
Department of Panchkarma, Gurukul Campus
Uttarakhand Ayurved University, Haridwar, Uttarakhand
Technoayurveda’s Practical SOP Panchakarma - 2nd edition
by Ayurmitra Prof Prasad KSR & Prof Meena S Deogade
High lights: 4 sections, 38 Chapters, A4 size 272 + 18 Pages Full color
Detailed Explanation, SOP formats with appropriate illustrations
Paper: 70 GSM Maplitho (Text) 300 GSM Art Card (Cover)
Pages: 292 (Text) 4 Pages (Cover)
Print: 4-color (1-sided & inner side no print) (Text and Cover)
Size: 8.25 x 10.75 inches
Finish: Matte Lamination for Cover & Back, Perfect-binding for book with side-stitching
More Details of the Book at - https://technoayurveda.com/practical-sop-panchakarma/
Ayurmitra Nadi Bhishak Jyotisha Vaidya Prof Dr KSR Prasad explanation on Ayur-Jyotisham (Ayurveda Astrology) on the basis of Nakshatra Vriksha and Unique method of technoayurveda developed Cosmic anatomy and Cosmic Energy Garden - Jyotisha (Nakshtra) Vana.
Virechana Introduction, Seasonal administration and Agni intervention Guest lecture by Ayurmitra Nadibhishak, Jyotisha Vaidya Dr KSR Prasad at GAC Varanasi
Ayurmitra & Nadi Guru
Prof KSR Prasad (Technoayurveda)
9290566566/9503227966 / technoayurveda@yahoo.com
Lifestyle is a combination of determining intangible or tangible factors – the diseases generates because of are Lifestyle disorders
Jariatric (Geriatric) Psychological Trauma Management Through Ayurveda by Ayurmitra, Nadi Bhishak Prof KSR Prasad on 20-02-2021 @ SHRI HINGULAMBIKA AYURVEDIC MEDICAL COLLEGE AND HOSPITAL KALABURGI, KANATAKA
Selection of Bahya Snehana Techniques in Panchakarma by Ayurmitra, Nadi Bhishak, Prof KSR Prasad (Technoayurveda), Professor & Head, Panchakarma, LN Ayurved College, Bhopal, MP, 9290566566/9503227966 - technoayurveda@yahoo.com at eAyurshala Web Learning Ayurved Academy online lecture series on *Keraliya Panchakarma, 21st October 2020
Role of Vamana & Virechana in Lifestyle disorders by Ayurmitra Nadi Bhishak Prof KSR Prasad (Technoayurveda) in National Webinar On Role of Panchakarma in Lifestyle Disorders
On 15-09-2020 @ 2PM Panchakarma Dept, Govt PG Ayurveda College, Varanasi
Ayurmitra Nadi Bhishak Prof KSR Prasad (Technoayurveda) lecture on Precautionary measures & post COVID
management through Panchakarma
All Panchakarma are done even in COVID and
post COVID situations as per Ayurveda principles
following precautions
Viruddha Ahara referred in terms of food to food interactions or food processing interactions develops Toxicity because of antagonism. - by Ayurmitra Nadi Guru Prof KSR Prasad (Technoayurveda) 9290566566/9503227966 ‐ technoayurveda@yahoo.com
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Dhanyamla bahiparimarjana
1. Dhanyamla Bahiparimarjana
Prof. Dr. K. Shiva Rama Prasad 1 ,
Parimarjana is spectacular word from Ayurvedic literature defined from Shabdha Kalpa
druma as – “Parishodhana”1 – a search, colloquially used to clean i.e. Dhavana. Where in the
“Marjana” is added with “Anganirmalyokaranam”2, which means the body waste removal process.
The “Parimarjana” with a prefix of “Bahi” becomes the “Bahiparimarjana” – a complete externally
modulated waste material removal or cleansing treatment, one out of three main methods of
treatment classifications. The other two are “Antahparimarjana” and “Shastrapranidhana”. The
“Pranidhana”3 has a meaning of – “the visualization of the cause of the Sthambha – the obstruction.
It other wise refer to the laparotomy exploration and Medinikosha explains it as “Praveshanam” –
the entry - of course in to abdomen.
Bahiparimarjana Chikitsa explained as – the treatment procedures that are depend upon the
external touch such as Abhyanga, Sweda, Pradeha, Parisheka, Unmardana, etc4. A close look at the
said examples makes a classification of the Bahiparimarjana Chikitsa i.e. trans-dermal cleansing
management. The former Abhyanga in terms of Bahya sneha is an external oil application where
heat inducted through rubbing. It is in the texts as not to apply any form of external (tropical)
managements with out unctuous application, in terms that lubricates and facilitates the absorption
of the tropical management. The second application Sweda is an external heat modulation or
transportation through steam. The rest of the treatment applications include either of these two
specific methods of heat transportations.
Commonly these Sneha and Sweda administered before to the chief cleansing methods viz.
Panchakarma. However, the real utility of Bahiparimarjana as “Roga Prashamana” visualized only
after the completion of the Dosha elimination. This verse observed from the Charaka at the context
of Kusta relay is that the Lepa applied after the eliminative (Samshodhita Ashaya) procedures are
effective5.
Human body is not depends upon the Sun heat and very minimal heat is taken from external
and depends upon the internal system to generate the heat required for the body maintenance. The
Dosha in the body are always fluctuating in nature enhances or dislodges from its places to give rise
physiological or pathological changes in the body. All these changes generally depend upon the
triad of mass, pressure and temperature. Out of these the mass and pressure in the body are constant
and the only temperature is the variant subjected for the pressure variances. Thus the managements
1
H.O.D., Dept. of Kayachikitsa (PG), DGM Ayurvedic Medical College, Kalasapur Road, Gadag-
582103, Karnataka (cell: +91-9448746450), doctorksrprasad@gmail.com
Dhanyamla Bahiparimarjana by Prof. Dr. K. Shiva Rama Prasad 1
2. of Dosha triad either for elimination or for the maintenance requires the cleansing from internally
and even externally, where the externally mediated procedures are not eventually cleansing in
nature they may be curative. For the same reason the externally mediated - Bahiparimarjana
Chikitsa methods viz. Sneha and Sweda are not included in the cleansing methods of Panchakarma.
These Sneha and Sweda along with the co- procedures are not possessing “Dosha nirharana
samardhya” i.e. eliminative capacity6. Therefore, these procedures administered later to the
cleansing are effective to disease relief. In a nut shell, Bahiparimarjana is a Dosha shamana and the
Antahparimarjana is Dosha Shodhana or doshavasechana management.
Dalhana was the first person to comment over the absorption and pharmaco-dynamics of the
externally mediated unctuous (fatty oil base) materials at the context of Abhyanga. He affirms that
each 100 of matra (32sec approximately) initiated from 300 to 900 takes the oil based medicament
for the Roma koopa – Twak – Rakta – Mamsa – Medo – Asthi – Majja. At the context he applies a
note that the Tridosha diseases of such region are implied to alter with the effect of medicine, as the
Abhyanga is Kapha Vata nirodhana 7. At the same place author, refer the Grudhrasi a disease,
prevented by the constant use of Abhyanga, which relays the meaning of Bahiparimarjana as
prevention and curative but not eliminative method of management. In the procedure of
Bahiparimarjana, the absorption is minimal but heat conduction is massive, that affect the blood to
flow peripheral to visceral or vice versa. The understanding of contemporary philosophy tells us
how our tradition meets the present day science.
Absorption through the skin can be enhanced by suspending the drug in an oily vehicle and
rubbing the resulting preparation into the skin. This method of administration is known as
inunction i.e. Abhyanga. Because hydrated skin is more permeable than dry skin, the dosage form
may be modified or an occlusive dressing may be used to facilitate absorption. Controlled-release
topical patches are recent innovations. Finally, intact stratum corneum is an excellent barrier, but in
disease states the resistance to absorption is rapidly lost and absorption can be facilitated. The skin
acts as a two-way barrier to prevent absorption or loss of water and electrolytes.
Few drugs readily penetrate the intact skin. Absorption of those that do is proportional to
the surface area over which they are applied and to their lipid solubility, since the epidermis
behaves as a lipid barrier. Inflammation and other conditions that increase cutaneous blood flow
also enhance absorption. The dermis, however, is freely permeable to many solutes. The diffusion
coefficient indicates the extent to which the matrix of the barrier restricts the mobility of the drug.
Increases in the molecular size of the drug will increase frictional resistance and decrease the
diffusion coefficient (Franz, 1983); molecules over 1000 daltons usually will not be absorbed
easily into normal adult skin8.
Dhanyamla Bahiparimarjana by Prof. Dr. K. Shiva Rama Prasad 2
3. Parameters Controlling Absorption in Bahiparimarjana Chikitsa
The absorption of drug into the skin is a function of the nature of the drug, the behaviour of
the vehicle, and the status of the skin. Three major variables account for differences in the rate of
absorption or flux of different topical drugs or of the same drug in different vehicles:
- The concentration of drug in the vehicle,
- The partition coefficient of drug between the stratum corneum and the vehicle, and
- The diffusion coefficient of drug in the stratum corneum.
Apart from the above the points to be considered are -
- Large Surface area enhance absorption
- Increase cutaneous blood flow also enhance absorption
- Body temperature and blood flow enhance absorption of tropical medicines
- Transdermal replacement therapy is not a new invention, exists since the birth of
Ayurveda
Factor influencing Bahiparimarjana Chikitsa (Topical Therapy)
Dosage:
An amount of topical medication sufficient to cover affected body surfaces in repeated
applications must be dispensed or applied to the patient. In Ayurveda much of applications viz.
Abhyanga, Sweda, Parisheka and Avagaha are done once in a day.
Age:
Children have a greater ratio of surface area to mass than adults, and a given amount of
topical drug results in a greater systemic dose. The permeability of children's skin is increased in
preterm infants (Barker et al., 1987).
Regional Anatomic Variation:
Permeability is generally inversely proportional to the thickness of the stratum corneum i.e.
Avabhasini. However, in certain areas, differences in lipid concentration may affect percutaneous
absorption, depending on an individual drug's lipophilicity (Having an affinity for lipids) or
hydrophilicity (Having an affinity for water).
Drug penetration is higher on the face, in inter-triginous areas, and especially in the
perineum. Thus these areas are minimal exposed to Bahiparimarjana Chikitsa. Consequently,
sensitization, irritation, and atrophy from Bio-steroids are more likely to develop in these regions.
Altered Barrier Function:
In many dermatological diseases, the stratum corneum is abnormal, and barrier function is
lost. Thus not through rub is indicated, more over many Bahiparimarjana Chikitsa are light in
touch.
Dhanyamla Bahiparimarjana by Prof. Dr. K. Shiva Rama Prasad 3
4. Application Frequency:
Topical agents are often applied twice daily. However, for certain drugs, once-daily
application of a larger dose may be as effective as more frequent application of smaller doses. The
stratum corneum may act as a reservoir and allow gradual penetration of a drug into the viable skin
layers over a prolonged period of time.
Hydration:
Drug absorption is increased with hydration, defined as an increase in the water content of
the stratum corneum that is produced by inhibiting trans-epidermal loss of water. Methods of
hydration include occlusion with an impermeable film, application of lipophilic occlusive vehicles
such as Taila, and soaking dry skin before occlusion. Many of the Ayurvedic preparations used in
Bahiparimarjana Chikitsa are water based or water soluble medicines transformed lipophilic
agents.
Vehicle:
Topical therapy is delivered by various vehicles, most frequently soaks, lotions, solutions,
creams, and ointments, progressing in that order from least to most hydrating. The choice of
vehicle may be as important as the active drug. In Ayurveda it is with many vehicles as Kashaya,
Taila or Dhanyamla.
An experimental modal of Dhanyamla prepared in DGM Ayurvedic Medical College,
Gadag for want of multi centric study in 2001 – 2003. It facilitated few single case studies and an
extended study over Amavata as Kayaseka. The literature and the procedure followed to
standardize the Dhanyamla are narrated here under.
DHANYAMLA 9
Before going into the details of Dhanyamla Kayaseka it is necessary to understand the term
Dhanyamla. A cursory glance itself reveals that the term “Dhanyamla “ is conjugate of two
different words, viz ‘Dhanya’ and ‘Amla’ which in conjugation means ‘fermented cereal’ in a
broad sense. All the three major classics of Ayurveda at some instance or other have referred to its
use at times, singularly or along with other drugs. Maharshi Charaka, Susruta and Vagbhata have
included this either in Amlavarga, Santhana kalpana or in Madya vargha. Charaka further
mentioned the drugs used for Dhanyamla in Nadi sweda and Upanaha.
Synonyms of Dhanyamla
A perusal of the ancient text of the medicine reveals that a number of synonyms have been
attributed to Dhanyamla which in most cases refer to a specific attribute and when taken
collectively gives a clear idea about the character and properties of Dhanyamla. Narisimha has in
this context very rightly stated that these synonyms to Dhanyamla are complementary to each other
Dhanyamla Bahiparimarjana by Prof. Dr. K. Shiva Rama Prasad 4
5. and as such there is no difference between ‘Dhanyamla’ and ‘Kanjhika’. ‘Guna deepika’, a
celebrated lexicon on medical plants gives the following compilations of synonyms as attributed to
Dhanyamla.
1. Aranala: ‘Aranalasya rigathownala gandha‘ i.e having acrid fast spreading odour.
2. Abhishuta: ‘shunj abhishave’ i.e made of half cooked cereals.
3. Avanthisoma: prepared out of ‘soma’ found in Avanti Desha.
4. Kulmasha: ‘Kula samsthyana’ i.e having half cooked ‘masha’ or black grain.
5. Kunjala: Indicative of fermented water.
6. Sowveeraka: Found in Sowveera desha.
Among these, Sowveerka’ and ‘Avantisoma’ are synonyms pertaining to geographical
preponderance or indicative of place. Abhishuta, Dhanyamla, KunJala, Kulmasha etc are indicative
of the process of fermentation. Aranala speaks of its acidic odour.
Properties of Dhanyamla
The known fact that Dhanyamla, amla or sour in taste serves as an aid in delving into other
properties of the Ama in the sense that since it is Amla in Rasa the associated qualities of Amla
Rasa as stated in the classics, viz, Laghu, Ushna, Snigdha, Deepana, Vatanulomana etc. can be
safely attributed to it. The properties of Dhanya like Brimhana, Tarpana, Balya and Vatahara are
also supplemented.
In brief, Dhanyamla cumulatively possess the following properties.
• Rasa - Amla
• Guna - Laghu, Snigdha, Teekshna, Sheeta sparsa
• Vipaka - Amla
• Veerya - Ushna
General properties of Dhanyamla
Many properties are attributed to Dhanyamla are - Deepana, Pachana, Rochana, Bhedi,
Vibhandhahrasa, Hrudya, Klamahara, Angasada hara, Dahajwarahara, Hrudrogahara, Panduhara,
Krimighna, Arshohara, Grahanihara, and Bastisulahara. It can be used even for Astapana. Among
other indications for its use, Charaka has specified its use in Daha jwara where in Avagaha of the
patients in Kanji has been recommended10. Same procedure is indicated to relieve pain in Arshas 11
even. Further in Rajayakshma when Prathishyaya and Peenasa are super imposed, renders the
ailment complicated. At this juncture the Nadi sweda with Kanji (Dhanyamla) has been
advocated12. Since Amla is Sheeta sparsa and acts so in external wage, Charaka has felt safe to
vouch for its use externally as Lepa, Seka etc. in Urusthambha also; he mentioned the use of the
drug Dhanyamla 13.
Dhanyamla Bahiparimarjana by Prof. Dr. K. Shiva Rama Prasad 5
6. In short while going through the references of the use of Dhanyamla in different context as
found in classics, it is able to conclude that the drugs which are used for the preparation of the
Dhanyamla and Dhanyamla as such are preferred in Vatarogas and Vatakapha samsargha janya
diseases.
Method of preparation of Dhanyamla 14
Dhanyamla can be prepared out of different methods. Many drugs in this yoga are easily get
fermented. Traditional physicians of Kerala generally follow present Yoga combination and
proportion is obtained from Sahasrayoga is as follows:
1 Tandula (Oryza sativa) 5 parts
2 Pruthuka (Pressed form of Oryza sativa) 5 parts
3 Kulatha Dolichos biflorus) 5 parts
4 Laja (Puffed form of Oryza sativa) 20 parts
5 Kangubeeja (Setaria italica) 4 parts
6 Kodravam (Paspalum scrobiculatum) 2 parts
7 Nagara (Zingiber officinale) 1 part
8 Nimbuka (Citrus acida) 4 parts
9 Dipyaka (Carum roxburgianum) 2 parts
10 Water 100parts
On an auspicious day at a time when the astral combinations are favourable, the necessary
drugs and Paraphernalia for the preparation of the Dhanyamla are to be collected. Place a large
deep earthenware pot on an oven and pour 200 Prasthas of boiled water and put the powdered drugs
1-9 separately made into loose bundles in clean cloth bags.
After putting these drugs into the vessel along with water, it has to be loosely covered with
a lid and heated gently and continuously in moderate fire, preferably of paddy husks, for a period of
7 days. The paddy husks are to be put under and around the vessel and fired taking every precaution
that the temperature of the water in the vessel does not rise above the boiling point. On the 8th day
the required quantity of the liquid is taken out and added same quantity of hot water. The important
factors to be recommended during the preparation of Dhanyamla is that - Absolute cleanness
should be maintained and Moderate fire should be kept through out he preparation
The details identification and proprties of the Dhanyamla ingredients are as follows -
1. TANDULA (N.O. Graminae, L. N. Oryza sativa) : Tandula possesses Madhura and Kashaya
Rasa, Madhura Vipaka as Sheeta Veerya. By Guna it is Guru. It alleviates Pitta Dosha and
provokes Kapha Dosha.
Dhanyamla Bahiparimarjana by Prof. Dr. K. Shiva Rama Prasad 6
7. 2. PRUTHUKA (N.O. Graminae, L.N. Oryza sativa): It is made out of Tandula. Prepared by little
heating and wet pounding of Tandula.
3. KULATHA (N.O. Leguminoceae, L.N. Dolichos biflorus): Kulatha possesses Kashaya Rasa,
Katu Vipaka and Ushna Veerya. By Guna it is Laghu, Vidahi and Sara. It acts as Kapha
Vatahara. It provokes Pitta Dosha also.
4. LAJA (N.O. Graminae, L.N. Oryza sativa): It is made out of Tandula. Prepared by dry frying in
a small-mouthed vessel. This process is known to induce Laghu Guna.
5. KANGUBIJA (N.O. Graminae, L.N. Setaria italica): Kangubija possesses Kashaya and
Madhura Rasa, Katu Vipaka and Ushna Veerya. By Guna it is Guru and Ruksha. It acts as
KaphaPitta shamaka and Vata vardhaka. It possesses Sandhaneeya and Vrushya properties.
6. KODRAVA (N.O. Graminae, L.N. Paspalum scrobiculatum): Kodrava is of Madhura-Kashaya
in Rasa, Katu in Vipaka and Sheeta in Veerya. By Guna it is Laghu and Ruksha. It alleviates
Kapha and Pitta Dosha and provokes Vata Dosha.
7. NAGARA: Already described in Alambushadi Yoga.
8. NIMBUKA (N.O. Rutaceae, L.N. Citrus acida): Nimbuka is of Amla Rasa, Amla Vipaka and
Ushna Veerya. By Guna it is Laghu. It pacifies kapha Dosha. It has got Agnideepana, Rochana,
Pachana and Trishnanigraha properties.
9. DIPYAKA (N. O. Umbelliferae, L.N. Carum roxburgianum): Dipyaka possesses Katu and
Tikta Rasa, Katu Vipaka and Ushna Veerya. By Guna it is Laghu, Ruksha. It acts as Samaka for
Kapha and Vata Dosha. It has got Shoola Prashamana, Rochana and Krimighna properties.
PHYSIOCHEMICAL ANALYSIS REPORT (Analyzed at K.L.E. society’s Pharmacy
college, Gadag.)
01. PH = 3.03
02. Specific gravity = 1.01
03. Test for Alkaloids
a. Mayer’s Test = Positive
b. Hager’s Test = Positive
04. Test for Carbohydrates
a. Molish Test = Positive (Carbohydrate present)
b. Benedict’s Test = Positive (Reducing sugar present)
c. Barfoedt’s Test = Positive (Monosaccherides present)
Dhanyamla Bahiparimarjana by Prof. Dr. K. Shiva Rama Prasad 7
8. Case studies with Dhanyamla
Pakashaghata: As the Dhanyamla indication is for all Vata Vyadhi, Pakshaghata was tried with
internally for pana and externally with kayaseka. The patient initially with Dakshina Pakshaghata
recovered in 14 days management, without any drawbacks or setbacks.
Sandhivata: Eight patients of Sandhivata are undertaken for observational study with Dhanyamla
Dhara over the Sandhi, which made the patient to have symptomatic relief with in seven days of
course.
15
Amavata: Nine patients of Amavata were treated with Dhanyamla Kayaseka for 21 days. The
results obtained with objective and subjective parameters are as follows.
1. Comprehensive statements of objective parameters are as follows.
% of
Parameter Mean Mean Difference improve
SN before after of Mean ment SD SE t value p value Remarks
Pain in Numerical rating
1 scale 15.22 5.56 9.11 65.77 2.02 1.60 8.12 < 0.001 H. S
Pain in Visual Analogue
2 scale 66.67 23.33 34.89 67.05 4.06 2.10 8.19 < 0.001 H. S
3 Swelling of 44 joints 14.67 4.89 7.33 71.80 2.24 1.10 8.87 < 0.001 H. S
4 Swelling of 28 joints 13.22 4.67 7.67 70.62 2.26 1.34 6.36 < 0.001 H. S
5 Tenderness of 28 joints 14.56 6.00 9.67 62.40 2.22 1.16 6.91 < 0.001 H. S
6 Morning stiffness 2.44 1.33 1.67 44.44 0.70 0.20 5.55 < 0.001 H. S
7 Heaviness 1.22 0.33 1.11 77.78 0.67 0.11 8.00 < 0.001 H. S
8 RA index (tenderness) 17.22 6.44 12.78 64.02 2.37 1.69 6.35 < 0.001 H. S
Madhavakara index of
9 Amavata 12.78 3.22 13.22 76.35 2.09 1.70 5.59 < 0.001 H. S
Anjana nidana index of
10 Amavata 7.56 3.56 6.44 54.78 1.35 0.44 9.07 < 0.001 H. S
11 Basavarajeya index 1.89 1.00 2.11 31.67 1.12 0.35 2.53 < 0.05 H. S
Extra articular
12 manifestation 3.33 1.11 2.00 72.09 1.20 0.32 6.86 < 0.001 H. S
Global disease assessment
13 (patient's) 59.22 18.11 43.00 70.16 3.75 1.80 8.20 < 0.001 H. S
Global disease assessment
14 (physician's) 64.44 25.00 37.22 61.94 4.08 1.84 5.92 < 0.001 H. S
Ayurvedic health
15 assessment 36.56 20.56 21.11 43.72 1.96 1.00 16.00 < 0.001 H. S
Arthritis impact
16 measurement scale 37.33 19.78 18.78 46.44 2.48 1.94 9.06 < 0.001 H. S
17 Physical disability 13.33 5.00 8.22 62.55 1.64 1.00 8.33 < 0.001 H. S
18 Walking time 55.00 45.22 11.00 17.65 1.97 1.06 9.19 < 0.001 H. S
19 Grip strength 86.56 95.44 18.22 9.73 4.01 2.10 3.38 < 0.01 H. S
20 Range of movements 76.89 82.22 4.56 7.34 2.87 0.86 6.16 < 0.001 H. S
21 ESR 41.44 35.56 7.33 17.19 4.53 1.98 6.02 < 0.001 H. S
22 C reactive protein 0.44 0.33 0.44 11.11 0.70 0.11 1.00 > 0.05 N. S
23 Haemoglobin 11.02 11.32 0.10 2.87 0.88 0.16 1.93 > 0.05 N. S
24 Lymphocyte count 37.56 38.78 2.11 3.76 2.64 0.28 4.40 < 0.05 H. S
25 Disease activity score 4.76 2.78 2.47 42.71 0.96 0.19 10.13 < 0.001 H. S
Disease activity score - 28
26 joints 6.43 4.27 2.56 35.13 1.06 0.26 8.36 < 0.001 H. S
Dhanyamla Bahiparimarjana by Prof. Dr. K. Shiva Rama Prasad 8
9. 2. Sandhigraha :- In this Group four patients (44%) presented with Grade III and five patients
(56%) with Grade II Sandhigraha.After the treatment there was no patients with Grade III and
Grade II was reduced from five to three(33%).
3. Sandhiruk:- One patient presented with Grade III (11%), four patients with Grade II (44%), and
four patients with Grade I(44%). After the treatment Grade II was reduced from four to one
(11%) and four patients (44%) got complete relief.
4. Sandhisotha:- One patient presented with Grade III (11%) five patients with Grade II (56%) and
three patients with Grade I (33%). After the treatment three patients got complete relief (33%)
and there were no patients with Grade III. Number of patients in Grade II was reduced from
five to one (11%)
5. Sparsa asahishnuta:- One patient presented with Grade III (11%) five patients with Grade II
(56%) and three patients with Grade I (33%). After the treatment six patients got complete
relief (67%) and there were no patients with Grade II and Grade III.
6. Gourava :- Two patients presented with Grade II and seven patients with Grade I. After the
treatment six patients (67%) got complete relief and there were no patients with Grade II and
Grade III.
Conclusion:
At the virtue of understanding the fundamentals of the Bahiparimarjana Chikitsa - tropical
appliance management, it is very clear that the required cleansing properties such as “Anupravana
bhava Utpadakata” is not available with and they are said as only Dosha transport facilitators with
the capabilities of Vishyanda, Paka and Srotomukha Vishodhana, well before to the Dosha
Shodhana procedure. When Dosha Shodhana is done the same Bahiparimarjana Chikitsa becomes
potent to pacify Dosha and said as Dosha shamaka. Dhanyamla is such potent externally mediated,
temperature regulated, lipophilicity, moistened, pH regulated (3 approx.), concentration - partition
and diffusion coefficient of drug is maintained along with specific Vata Dosha pacified properties.
Dermal applications which are hydrophobic in nature (organic solvents – Dhanyamla) utilized for sustaining
prolonged and slow delivery acts on systemic diseases. Thus the Dhanyamla Chikitsa becomes ultimate
treatment Antahparimarjana (internally) and Bahiparimarjana (externally) Chikitsa.
Dhanyamla Bahiparimarjana by Prof. Dr. K. Shiva Rama Prasad 9
10. References
1) Raja Radha Kanta Deva, Shabda Kalpa druma, part 3, 3rd ed, 1967, Chowkhamba Sanskrit Series
Office, PB No 8, Varanasi -1, pp 62
2) Ibid, pp 709
3) Ibid, pp 709 medina
4) Vaidya Jadavji Trikamji Acharya ed, Charaka Samhita sutra 11/55, Nirnaya Sagar Press (1941)
reprint, 1984, Chowkhamba Sanskrit sansthan, PB No 139, Varanasi, pp 78
5) Ibid, Chikitsa, 7/53, pp 453
6) Ibid, Sutra, 2/15 – Chakrapani, pp 25
7) Vaidya Jadavji Trikamji Acharya et.al., Susruta Samhita Chikitsa 24/30 - Dalhana, 8th ed, 2005,
Chowkhamba orientalia, PB No 1032, Varanasi, pp 488
8) Joel G. Hardman et.al., Goodman & Gilman's THE PHARMACOLOGICAL BASIS OF
THERAPEUTICS, 9th ed, 1996, McGraw-Hill, Health Professions Division, New York
9) Sahasra yoga Edited by – Shri K. V. Krishnan Vaidyan et.al. Published by Vidyarabham Publishers,
Allepy, 23rd edition April 2000. Pp.122
10) Vaidya Jadavji Trikamji Acharya ed, Charaka Samhita Chikitsa 3/259, Nirnaya Sagar Press (1941)
reprint, 1984, Chowkhamba Sanskrit sansthan, PB No 139, Varanasi, pp 422
11) Ibid, 14/44-47, pp 508
12) Ibid, 8/74, pp 463
13) Ibid, 27/50-55, 615
14) Sahasra yoga Edited by – Shri K. V. Krishnan Vaidyan et.al. Published by Vidyarabham Publishers,
Allepy, 23rd edition April 2000. Pp.122
15) Shyju Ollakkod under the guidance of Dr. K. Shiva Rama Prasad, Evaluation of comparative
efficacy of Alambushadi yoga and Dhanyamla Kayaseka in Amavata (Rheumatoid Arthritis), 2004,
Department of Kayachikitsa (PG), Post graduate studies and research centre, D.G. M. AYURVEDIC
MEDICAL COLLEGE, Gadag - 582 103
Dhanyamla Bahiparimarjana by Prof. Dr. K. Shiva Rama Prasad 10